CBLN2 overexpression inhibits colorectal cancer progression and improves immunotherapy responses

Zeyu Wang(Anhui University), Jun Zhou(Emory Healthcare), Hui Pan(Zhejiang University)
International Immunopharmacology
November 21, 2024
Cited by 1


Related Papers